Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy.

Wang, Wei; Zhang, Weijie; Su, Lei; Sang, Jianfeng; Wang, Shui; Yao, Yongzhong

Wang, Wei; Zhang, Weijie; Su, Lei; Sang, Jianfeng; Wang, Shui; Yao, Yongzhong.

Afiliação

Wang W; Department of Breast Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Zhang W; Department of Breast Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Su L; Department of Breast Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Sang J; Department of Breast Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Wang S; Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210008, China.
Yao Y; Department of Breast Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.

Transl Cancer Res ; 8(4): 1531-1539, 2019 Aug.

Article em En | MEDLINE | ID: mdl-35116896

Palavras-chave

Breast neoplasms; biomarkers; cell-free nucleic acids; neoadjuvant therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Cancer Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google